Answers are grounded in this paper and cite their sources.
Patients with life-threatening asthma exacerbations who fail to improve on receiving standard and adjunctive therapies (eg, bronchodilators, glucocorticoids, magnesium, anesthetic/inhalational agents) are sometimes considered for extracorporeal membrane oxygenation (ECMO) as salvage therapy.1 However, reports describing ECMO initiation in patients with life-threatening asthma have varied in both the types of outcomes reported and their estimates. We synthesized the body of evidence, using meta-analyses to estimate the outcomes of adults with life-threatening asthma exacerbations who undergo ECMO.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: